Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

361

HTML

2884

Figures (1-1)

217

Tables (1-2)

203

Sum=3665

Mar 27, 2013 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Mar 27, 2013; 5(3): 120-126
Published online Mar 27, 2013. doi: 10.4254/wjh.v5.i3.120

Full Size Figure Download Figure

Figure 1 Flowchart of the selection of the studies. SOC: Standard of care; SAE: Severe adverse event.

Citation: Bota S, Sporea I, Şirli R, Popescu A, Neghină AM, Dănilă M, Străin M. Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review. World J Hepatol 2013; 5(3): 120-126
URL: https://www.wjgnet.com/1948-5182/full/v5/i3/120.htm
DOI: https://dx.doi.org/10.4254/wjh.v5.i3.120